Hepatitis C Co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients

Journal of Bone and Mineral Research

Volumn 28, Issue 12, 2013, Pages 2577-2583

  Maalouf, Naim M ^a   Zhang, Song ^a   Drechsler, Henning ^a,b   Brown, Geri R ^a,b   Tebas, Pablo ^c   Bedimo, Roger ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cirrhosis; fracture; hepatitis c; hiv; osteoporosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE TO PLATELET RATIO INDEX SCORE; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; GLOMERULUS FILTRATION RATE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP FRACTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTOR VARIABLE; RACE DIFFERENCE; REFERENCE DATABASE; RISK FACTOR; SMOKING; SPINE FRACTURE; THROMBOCYTE COUNT; WRIST FRACTURE;

CIRRHOSIS; FRACTURE; HEPATITIS C; HIV; OSTEOPOROSIS;

ADULT; COHORT STUDIES; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84888068330     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1988     Document Type: Article

References (37)

1. Triant VA, Brown TT, Lee H, Grinspoon SK., Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008; 93: 3499-504.
2. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT., Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010; 51: 937-46.
3. Young B, Dao CN, Buchacz K, Baker R, Brooks JT., Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis. 2011; 52: 1061-8.
4. Kuhne CA, Heufelder AE, Hofbauer LC., Bone and mineral metabolism in human immunodeficiency virus infection. J Bone Miner Res. 2001; 16: 2-9.
5. Brown TT, Qaqish RB., Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006; 20: 2165-74.
6. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE., Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000; 14: F63-7.
7. Bedimo R, Maalouf NM, Zhang S, Drechsler H, Tebas P., Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS. 2012; 26: 825-31.
8. Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, De Vernejoul MC., BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res. 2004; 19: 402-9.
9. Hansen AB, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Obel N., Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS. 2012; 26: 285-93.
10. Lo Re V 3rd, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR., Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/HIV Coinfection. Hepatology. 2012; 56: 1688-98.
11. Leslie WD, Bernstein CN, Leboff MS., AGA technical review on osteoporosis in hepatic disorders. Gastroenterology. 2003; 125: 941-66.
12. Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J., Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005; 11: 1843-7.
13. El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT., Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol. 2011; 55: 770-6.
14. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38: 518-26.
15. Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B, Fraenkel L, Mattocks K, Rimland D, Rodriguez-Barradas MC, Tate J, Yin MT, Justice AC., Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One. 2011; 6 (2): e17217.
16. Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB., Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004; 164: 2349-54.
17. Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG., Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS. 2012; 26: 599-607.
18. Collin F, Duval X, Le Moing V, Piroth L, Al Kaied F, Massip P, Villes V, Chene G, Raffi F., Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS. 2009; 23: 1021-4.
19. de Castro IF, Micheloud D, Berenguer J, Guzman-Fulgencio M, Catalan P, Miralles P, Alvarez E, Lopez JC, Cosin J, Lorente R, Munoz-Fernandez MA, Resino S., Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients. AIDS. 2010; 24: 2059-67.
20. Pawlak K, Mysliwiec M, Pawlak D., Hepatitis C virus seropositivity and TNF superfamily receptors: sCD40, sFas-the new putative determinants of endothelial dysfunction in haemodialysis patients. Thromb Res. 2010; 126: 393-8.
21. de Larranaga GF, Wingeyer SD, Puga LM, Alonso BS, Benetucci JA., Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment. Eur J Clin Microbiol Infect Dis. 2006; 25: 98-103.
22. Takahashi N, Maeda K, Ishihara A, Uehara S, Kobayashi Y., Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. Front Biosci. 2011; 16: 21-30.
23. Romas E, Gillespie MT., Inflammation-induced bone loss: can it be prevented?. Rheum Dis Clin North Am. 2006; 32: 759-73.
24. Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P., The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 2001; 34: 1193-9.
25. Martinez-Sierra C, Arizcorreta A, Diaz F, Roldan R, Martin-Herrera L, Perez-Guzman E, Giron-Gonzalez JA., Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis. 2003; 36: 491-8.
26. Al-Mohri H, Cooper C, Murphy T, Klein MB., Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med. 2005; 6: 375-8.
27. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL., HIV monoinfection is associated with increased aspartate aminotransferase-to- platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis. 2012; 205: 1005-13.
28. Mendeni M, Foca E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C., Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis. 2011; 52: 1164-73.
29. Merriman RB., Nonalcoholic fatty liver disease and HIV infection. Curr HIV/AIDS Rep. 2006; 3: 113-7.
30. Sterling RK, Smith PG, Brunt EM., Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. J Clin Gastroenterol. 2013; 47: 182-7.
31. van der Pas VR, Hoepelman AI, Arends JE, Letter to Mendeni et al. Clin Infect Dis. 2011; 53: 613-4. author reply 614-5.
32. Izzo IBL, Mendeni M, Prestini K, Vavassori A, Focà E, Quiros-Roldan E, Carosi G, Torti C., The use of ultrasonography, transient elastography, APRI and fib-4 to measure liver steatosis and fibrosis in HIV-positive patients not co-infected with hepatitis viruses with hypertransaminasemia of unknown etiology on HAART. Open Infectious Dis J. 2011; 5: 1-5.
33. Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Hosaka T, Kawamura Y, Yatsuji H, Hirakawa M, Ikeda K, Hsieh SD, Oomoto Y, Amakawa K, Kato H, Kazawa T, Tsuji H, Kobayashi T, Kumada H., Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus. J Med Virol. 2010; 82: 390-5.
34. Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, Bucker A, Mihm U, von Wagner M, Zeuzem S, Sarrazin C., Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J Viral Hepat. 2008; 15: 790-6.
35. Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP., Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011; 364: 1195-206.
36. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S., Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011; 364: 2405-16.
37. Campillo B, Richardet JP, Bories PN., Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol. 2006; 30: 1137-43.